Nuvalent, Inc. (NUVL) Misses Q2 EPS by 12c

Nuvalent, Inc. (NASDAQ: NUVL) reported Q2 EPS of ($0.88), $0.12 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Nuvalent, Inc. (NUVL) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• FDA grants accelerated approval to AstraZeneca's camizestrant combo
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)